Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.45 |
| ▸ | USP2 | O75604 | 3/20 | 0.45 |
| ▸ | CASP1 | P29466 | 3/20 | 0.45 |
| ▸ | CASP7 | P55210 | 3/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.45 |
| ▸ | BRCA1 | P38398 | 2/20 | 0.45 |
| ▸ | RECQL | P46063 | 2/20 | 0.45 |
| ▸ | HAT1 | O14929 | 2/20 | 0.45 |
| ▸ | RBBP7 | Q16576 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | HBB | P68871 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22830404 | 0.85 | GSR (0.52) | MEN1KMT2AKDM4EUSP2CASP1 | |
| SCHEMBL22830405 | 0.81 | MEN1 (0.68) | MEN1KMT2AKDM4EUSP2CASP1 | |
| SCHEMBL10250552 | 0.74 | KMT2A (0.51) | MEN1KMT2AKDM4EUSP2CASP1 | |
| SCHEMBL10250398 | 0.74 | MEN1 (0.53) | MEN1KMT2AKDM4EUSP2CASP1 | |
| SCHEMBL10250554 | 0.72 | KMT2A (0.46) | MEN1KMT2AKDM4EUSP2CASP1 | |
| SCHEMBL11304574 | 0.70 | GSR (0.45) | MEN1KMT2AKDM4ECASP1CASP7 | |
| SCHEMBL30935958 | 0.70 | MEN1 (0.67) | MEN1KMT2AKDM4EUSP2CASP1 | |
| SCHEMBL31481986 | 0.69 | MEN1 (0.66) | MEN1KMT2AKDM4EUSP2CASP1 | |
| SCHEMBL30176237 | 0.69 | MEN1 (0.68) | MEN1KMT2AKDM4EUSP2CASP1 | |
| SCHEMBL21743935 | 0.67 | MEN1 (0.63) | MEN1KMT2AKDM4EUSP2CASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1345491-B1 | STORAGE SOLUTION CONTAINING PHOTOSENSITIZER FOR INACTIVATION OF BIOLOGICAL CONTAMINANTS | GAMBRO INC (US) | 2006-04-05 | — | — | EP | claimed |
| EP-1404379-A2 | VIRAL INACTIVATION PROCESS USING ANTIOXIDANT | Gambro, Inc. (US) | 2004-04-07 | — | — | EP | claimed |
| US-20030215784-A1 | Method and apparatus for inactivation of biological contaminants using photosensitizers | TERUMO BCT BIOTECHNOLOGIES, LLC | 2003-11-20 | — | — | US | claimed |
| WO-2002096471-A2 | VIRAL INACTIVATION PROCESS USING ANTIOXIDANT | GAMBRO, INC. (US) | 2002-12-05 | — | — | WO | claimed |
| EP-3934594-A1 | ENERGY AUGMENTATION STRUCTURES, EMITTERS OR COLLECTORS, FOR USE IN NON-INVASIVE IN-SITU PHOTOBIOMODULATION | Immunolight, Llc. (US) | 2022-01-12 | — | — | EP | disclosed |
| WO-2010009106-A1 | ADVANCED METHODS AND SYSTEMS FOR TREATING CELL PROLIFERATION DISORDERS | BOURKE FREDERIC A JR (US) | 2010-01-21 | — | — | WO | disclosed |
| EP-1345491-B1 | STORAGE SOLUTION CONTAINING PHOTOSENSITIZER FOR INACTIVATION OF BIOLOGICAL CONTAMINANTS | GAMBRO INC (US) | 2006-04-05 | — | — | EP | disclosed |
| US-20040023201-A9 | A platelet/additive solution and treatment comprising bicarbonate, citrate and glucose | GAMBRO, INC. | 2004-02-05 | — | — | US | disclosed |
| US-20030186213-A1 | Blood component storage solutions containing a photosensitizer for viral inactivation | MCBURNEY LAURA (US) | 2003-10-02 | — | — | US | disclosed |
| EP-1345491-A1 | STORAGE SOLUTION CONTAINING PHOTOSENSITIZER FOR INACTIVATION OF BIOLOGICAL CONTAMINANTS | Gambro, Inc. (US) | 2003-09-24 | — | — | EP | disclosed |
| US-6548241-B1 | A fluid to be used in the decontamination treatment and inthe storage of blood or blood components containing a nutrient, 7,8-dimethyl-10-ribityl isoalloxazine, a buffer and an anticoagulant | GAMBRO, INC. | 2003-04-15 | — | — | US | disclosed |
| WO-2002043485-A1 | STORAGE SOLUTION CONTAINING PHOTOSENSITIZER FOR INACTIVATION OF BIOLOGICAL CONTAMINANTS | GAMBRO, INC. (US) | 2002-06-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030186213-A1 | Blood component storage solutions containing a photosensitizer for viral inactivation | HBG1, HBG2, HBB | MEN1 1975/4885KMT2A 3625/4885KDM4E 3877/4885 |
| US-20030215784-A1 | Method and apparatus for inactivation of biological contaminants using photosensitizers | PROC, PLG, PLPBP | MEN1 4813/4885KMT2A 3553/4885KDM4E 2962/4885 |
| US-20040023201-A9 | A platelet/additive solution and treatment comprising bicarbonate, citrate and glucose | PFKP, PF4, PDGFRB | MEN1 2094/4885KMT2A 4399/4885KDM4E 4569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.